A CT-based Radiomics Signature Is Associated with Response to Immune Checkpoint Inhibitors in Advanced Solid Tumors
Author:
Funder
Banco Bilbao Vizcaya Argentaria
Generalitat de Catalunya
Publisher
Radiological Society of North America (RSNA)
Subject
Radiology Nuclear Medicine and imaging
Link
http://pubs.rsna.org/doi/pdf/10.1148/radiol.2021200928
Reference34 articles.
1. Nivolumab for Patients With Advanced Melanoma Treated Beyond Progression
2. Nivolumab and Ipilimumab versus Ipilimumab in Untreated Melanoma
3. Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial
4. Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
5. Atezolizumab versus chemotherapy in patients with platinum-treated locally advanced or metastatic urothelial carcinoma (IMvigor211): a multicentre, open-label, phase 3 randomised controlled trial
Cited by 54 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Could the underlying biological basis of prognostic radiomics and deep learning signatures be explored in patients with lung cancer? A systematic review;European Journal of Radiology;2024-02
2. A novel sub-regional radiomics model to predict immunotherapy response in non-small cell lung carcinoma;Journal of Translational Medicine;2024-01-22
3. Artificial intelligence for predictive biomarker discovery in immuno-oncology: a systematic review;Annals of Oncology;2024-01
4. Imaging-Based Biomarkers Predict Programmed Death-Ligand 1 and Survival Outcomes in Advanced NSCLC Treated With Nivolumab and Pembrolizumab: A Multi-Institutional Study;JTO Clinical and Research Reports;2023-12
5. Computed Tomography-Based Radiomics for Long-Term Prognostication of High-Risk Localized Prostate Cancer Patients Received Whole Pelvic Radiotherapy;Journal of Personalized Medicine;2023-11-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3